Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Neoplasms

Explore clinical trials studying Fallopian Tube Neoplasms. Study availability and eligibility vary by location and protocol.

600 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Neoplasms trial results

Completed

Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

NCT01459380

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Augusta University Medical Center Augusta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 13 locations
View Trial Details
Completed

Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer

NCT01442051

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering West Harrison Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer

NCT01610869

Conditions
Adnexal Diseases, Carcinoma, Disease Attributes, +23 more
Locations
  • Kent Oncology Centre Maidstone, Kent, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom
  • Velindre Hospital Cardiff, Wales, United Kingdom
  • Royal United Hospital Bath, United Kingdom
View all 16 locations
View Trial Details
Completed

The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer

NCT01556841

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +21 more
Locations
  • Leeds Teaching Hospitals NHS Trust Leeds, West Yorkshire, United Kingdom
  • The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Wirral, United Kingdom
  • Brighton and Sussex NHS Foundation Trust Brighton, United Kingdom
  • University Hospitals of Bristol NHS Foundation Trust Bristol, United Kingdom
View Trial Details
Completed

A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT01846611

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations
  • Birmingham, Alabama, United States
  • Phoenix, Arizona, United States
  • Scottsdale, Arizona, United States
  • Sedona, Arizona, United States
View all 138 locations
View Trial Details

Related conditions